Fetal anemia due to non-Rhesus-D red-cell alloimmunization

Seminars in Fetal and Neonatal Medicine

Volumn 13, Issue 4, 2008, Pages 207-214

  Moise, Kenneth J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas Children's Fetal Center   (United States)

Author keywords

Hemolytic disease of the fetus newborn (HDFN); Irregular antibodies; Red cell alloimmunization

Indexed keywords

ANTIGEN; ERYTHROCYTE ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KELL 1 ANTIGEN; KELL 10 ANTIGEN; KELL 2 ANTIGEN; KELL 3 ANTIGEN; KELL 4 ANTIGEN; KELL 5 ANTIGEN; KELL 6 ANTIGEN; KELL 7 ANTIGEN; RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY; RHESUS G ANTIBODY;

ALLOIMMUNIZATION; ANTIBODY TITER; ARTICLE; BLOOD GROUP KELL SYSTEM; CONSERVATIVE TREATMENT; DISEASE SEVERITY; FETUS DISEASE; HEMOLYTIC ANEMIA; HEMOLYTIC DISEASE OF THE FETUS NEWBORN; HUMAN; PREGNANCY; PRENATAL PERIOD; PREVALENCE; PUERPERIUM; UNITED STATES;

ALGORITHMS; ANEMIA; FEMALE; FETAL DISEASES; HUMANS; ISOANTIBODIES; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; SEROLOGIC TESTS;

EID: 44649202015     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2008.02.007     Document Type: Article

References (61)

1. Bowman J.M. Treatment options for the fetus with alloimmune hemolytic disease. Transfus Med Rev 4 (1990) 191-207
2. van Kamp I.L., Klumper F.J., Bakkum R.S., et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 185 (2001) 668-673
3. Queenan J.T., Smith B.D., Haber J.M., et al. Irregular antibodies in the obstetric patient. Obstet Gynecol 34 (1969) 767-771
4. Geifman-Holtzman O., Wojtowycz M., Kosmas E., et al. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 89 (1997) 272-275
5. McKenna D.S., Nagaraja H.N., and O'Shaughnessy R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 93 (1999) 667-673
6. Bowell PJ, Brown SE, Dike AE, et al. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynaecol 86;93:1044-1048.
7. Wenk R.E., Goldstein P., and Felix J.K. Alloimmunization by hr′(c), hemolytic disease of newborns, and perinatal management. Obstet Gynecol 67 (1986) 623-626
8. Kozlowski C.L., Lee D., Shwe K.H., et al. Quantification of anti-c in haemolytic disease of the newborn. Transfus Med 5 (1995) 37-42
9. Hackney D.N., Knudtson E.J., Rossi K.Q., et al. Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol 103 (2004) 24-30
10. Spong C.Y., Porter A.E., and Queenan J.T. Management of isoimmunization in the presence of multiple maternal antibodies. Am J Obstet Gynecol 185 (2001) 481-484
11. Bowman J.M., Pollock J.M., Manning F.A., et al. Severe anti-C hemolytic disease of the newborn. Am J Obstet Gynecol 166 (1992) 1239-1243
12. Joy S.D., Rossi K.Q., Krugh D., et al. Management of pregnancies complicated by anti-E alloimmunization. Obstet Gynecol 105 (2005) 24-28
13. Huber A.R., Leonard G.T., Driggers R.W., et al. Case report: moderate hemolytic disease of the newborn due to anti-G. Immunohematology 22 (2006) 166-170
14. Hadley A.G., Poole G.D., Poole J., et al. Haemolytic disease of the newborn due to anti-G. Vox Sang 71 (1996) 108-112
15. Trevett Jr. T.N., and Moise Jr. K.J. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C. Obstet Gynecol 106 (2005) 1178-1180
16. Bowman J.M., Pollock J.M., Manning F.A., et al. Maternal Kell blood group alloimmunization. Obstet Gynecol 79 (1992) 239-244
17. 450 value in amniotic fluid. Obstet Gynecol 60 (1982) 746-749
18. Caine M.E., and Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 154 (1986) 85-90
19. Vaughan J.I., Warwick R., Letsky E., et al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 171 (1994) 247-252
20. Weiner C.P., and Widness J.A. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 174 (1996) 547-551
21. Vaughan J.I., Manning M., Warwick R.M., et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 338 (1998) 798-803
22. van Wamelen D.J., Klumper F.J., de Haas M., et al. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstet Gynecol 109 (2007) 1093-1098
23. Oepkes D., Seaward P.G., Vandenbussche F.P., et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 355 (2006) 156-164
24. van Dongen H., Klumper F.J., Sikkel E., et al. Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies. Ultrasound Obstet Gynecol 25 (2005) 341-345
25. Rimon E., Peltz R., Gamzu R., et al. Management of Kell isoimmunization-evaluation of a Doppler-guided approach. Ultrasound Obstet Gynecol 28 (2006) 814-820
26. Bowman J.M., Harman F.A., Manning C.R., et al. Erythroblastosis fetalis produced by anti-k. Vox Sang 56 (1989) 187-189
27. Levine P., Backer M., and Wigod M. A human blood group property (Cellano) present in 99.8% of all bloods. Science 109 (1949) 464-466
28. Bryant L.B. A case of anti-cellano (k) with review of the present status of the Kell blood group system. Bull South Central Assoc Blood Banks 8 (1965) 4-13
29. Moncharmont P., Juron-Dupraz F., Doillon M., et al. A case of hemolytic disease of the newborn infant due to anti-K (Cellano). Acta Haematol 85 (1991) 45-46
30. Kulich V. Hemolytic disease of the newborn caused by anti-k antibody. Cesk Pediatr 22 (1967) 823-826
31. Duguid J.K., and Bromilow I.M. Haemolytic disease of the newborn due to anti-k. Vox Sang 58 (1990) 69
32. Rigal D., Juron-Dupraz F., Biggio B., et al. [Fetal death and benign hemolytic disease of the newborn from anti-Cellano alloimmunization: 2 new case reports]. Rev Fr Transfus Immunohematol 25 (1982) 101-104
33. Stone B., and Marsh W.L. Hemolytic disease of the newborn caused by anti-M. Br J Haemotol 5 (1959) 344-347
34. Macpherson C.R., and Zartman E.R. Anti-M antibody as a cause of intrauterine death: a follow-up. Am J Clin Pathol 43 (1965) 544-547
35. Matsumoto H., Tamaki Y., Sato S., et al. A case of hemolytic disease of the newborn caused by anti-M: serological study of maternal blood. Acta Obstet Gynaecol Jpn 33 (1981) 525-528
36. Furukawa K., Nakajima T., Kogure T., et al. Example of a woman with multiple intrauterine deaths due to anti-M who delivered a live child after plasmapheresis. Exp Clin Immunogenet 10 (1993) 161-167
37. Duguid J.K., Bromilow I.M., Entwistle G.D., et al. Haemolytic disease of the newborn due to anti-M. Vox Sang 68 (1995) 195-196
38. Kanra T., Yuce K., and Ozcebe I.U. Hydrops fetalis and intrauterine deaths due to anti-M. Acta Obstet Gynecol Scand 75 (1996) 415-417
39. De Young-Owens A., Kennedy M., Rose R.L., et al. Anti-M isoimmunization: management and outcome at the Ohio State University from 1969 to 1995. Obstet Gynecol 90 (1997) 962-966
40. Corfield V.A., Moolman J.C., Martell R., et al. Polymerase chain reaction-based detection of MN blood group-specific sequences in the human genome. Transfusion 33 (1993) 119-124
41. Mayne K.M., Bowell P.J., Green S.J., et al. The significance of anti-S sensitization in pregnancy. Clin Lab Haematol 12 (1990) 105-107
42. Feldman R., Luhby A.L., and Gromisch D.S. Erythroblastosis fetalis due to anti-S antibody. J Pediatr 82 (1973) 88-91
43. Levine P., Ferraro L.R., and Koch E. Haemolytic disease of the newborn due to anti-S. Blood 7 (1952) 1030-1037
44. Griffith T.K. The irregular antibodies: a continuing problem. Am J Obstet Gynecol 137 (1980) 174-177
45. Davie M.J., Smith D.S., White U.M., et al. An example of anti-s causing mild haemolytic disease of the newborn. J Clin Pathol 25 (1972) 772-773
46. Telischi M., Behzad O., Issitt P.D., et al. Hemolytic disease of the newborn due to anti-N. Vox Sang 31 (1976) 109-116
47. Smith G., Knott P., Rissik J., et al. Anti-U and haemolytic disease of the fetus and newborn. Br J Obstet Gynaecol 105 (1998) 1318-1321
48. Burki U., Degan T., and Rosenfield R. Stillbirth due to anti-U. Vox Sang 9 (1964) 209-211
49. Austin T.K., Finklestein J., Okada D.M., et al. Letter: Hemolytic disease of newborn infant due to anti-U. J Pediatr 89 (1976) 330-331
50. Dhandsa N., Williams M., Joss V., et al. Haemolytic disease of the newborn caused by anti-U. Lancet 2 (1981) 1232
51. Gottschall J.L. Hemolytic disease of the newborn with anti-U. Transfusion 21 (1981) 230-232
52. Magaud J.P., Jouvenceaux A., Bertrix F., et al. [Perinatal hemolytic disease due to incompatibility in the U system. Arch Fr Pediatr 38 (1981) 769-771
53. Alfonso J.F., and de Alvarez R.R. Maternal isoimmunization to the red cell antigen U. Am J Obstet Gynecol 81 (1961) 45-48
54. Tuck S.M., Studd J.W., and White J.M. Sickle cell disease in pregnancy complicated by anti-U antibody. Case report. Br J Obstet Gynaecol 89 (1982) 91-92
55. Dopp S.L., and Isham B.E. Anti-U and hemolytic disease of the newborn. Transfusion 23 (1983) 273-274
56. Gonsoulin W.J., Moise Jr. K.J., Milam J.D., et al. Serial maternal blood donations for intrauterine transfusion. Obstet Gynecol 75 (1990) 158-162
57. Weinstein L., and Taylor E.S. Hemolytic disease of the neonate secondary to anti-Fya. Am J Obstet Gynecol 121 (1975) 643-645
58. Hessner M.J., Pircon R.A., Johnson S.T., et al. Prenatal genotyping of the Duffy blood group system by allele-specific polymerase chain reaction. Prenat Diagn 19 (1999) 41-45
59. Kim W.D., and Lee Y.H. A fatal case of severe hemolytic disease of newborn associated with anti-Jk(b). J Korean Med Sci 21 (2006) 151-154
60. Hessner M.J., Pircon R.A., Johnson S.T., et al. Prenatal genotyping of Jk(a) and Jk(b) of the human Kidd blood group system by allele-specific polymerase chain reaction. Prenat Diagn 18 (1998) 1225-1231
61. Finning K., Martin P., Summers J., et al. Fetal genotyping for the K (Kell) and RhC, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 47 (2007) 2126-2133. *The most important references are indicated with an asterisks.